Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

BACKGROUND: Despite the use of modern immunochemotherapy regimens, a significant proportion of diffuse large B-cell lymphoma (DLBCL) patients will relapse. We proposed absolute lymphocyte count/absolute monocyte count ratio (ALC/AMC ratio) as a new prognostic factor in relapsed or primary refractory...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan-Li, Gu, Kang-Sheng, Pan, Yue-Yin, Jiao, Yang, Zhai, Zhi-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033684/
https://www.ncbi.nlm.nih.gov/pubmed/24884604
http://dx.doi.org/10.1186/1471-2407-14-341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033684/
https://www.ncbi.nlm.nih.gov/pubmed/24884604
http://dx.doi.org/10.1186/1471-2407-14-341

Ejemplares similares